Literature DB >> 6238822

The activity of vancomycin and teicoplanin alone and in combination with gentamicin or ampicillin against Streptococcus faecalis.

H Y Chen, J D Williams.   

Abstract

The in vitro activities of vancomycin and teicoplanin against 56 strains of Streptococcus faecalis were compared. Killing curves showed that vancomycin and teicoplanin were bacteriostatic and that synergy was achieved when each was combined with gentamicin. The bactericidal activity displayed by 4 mg/l of ampicillin against Streptococcus faecalis was antagonized by 4 mg/l of vancomycin and 0.5 mg/l of teicoplanin respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238822     DOI: 10.1007/bf02017366

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  7 in total

1.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

2.  Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.

Authors:  M H Cynamon; P A Granato
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

3.  Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci.

Authors:  R C Moellering; A N Weinberg
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

4.  Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine.

Authors:  G M Sheldrick; P G Jones; O Kennard; D H Williams; G A Smith
Journal:  Nature       Date:  1978-01-19       Impact factor: 49.962

5.  The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci.

Authors:  H Y Chen; J D Williams
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

6.  In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.

Authors:  A Bauernfeind; C Petermüller
Journal:  Eur J Clin Microbiol       Date:  1982-10       Impact factor: 3.267

7.  Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci.

Authors:  C Watanakunakorn; C Bakie
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

  7 in total
  3 in total

Review 1.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.

Authors:  R Leclercq; E Bingen; Q H Su; N Lambert-Zechovski; P Courvalin; J Duval
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.

Authors:  J P Maskell; A M Sefton; J Yong; S J Chi; J D Williams
Journal:  Infection       Date:  1988       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.